medigraphic.com
ISSN 0210-5187 (Digital)

2015, Número 3

<< Anterior Siguiente >>

Med Cutan Iber Lat Am 2015; 43 (3)


Dermatosis neutrofílicas

Del Río, DY, Velásquez MM, Vargas GA, Correa LA

Idioma: Español
Referencias bibliográficas: 52
Paginas: 173-186
Archivo PDF: 596.57 Kb.


RESUMEN

Las dermatosis neutrofílicas constituyen un grupo de dermatosis no infecciosas que presentan en la histología un infiltrado inflamatorio en el que los neutrófilos predominan; asimismo, poseen un amplio espectro de manifestaciones clínicas, enfermedades de base asociadas y una adecuada respuesta al tratamiento con corticosteroides. En esta revisión se hace referencia, en orden de frecuencia, a las principales enfermedades representativas de este grupo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Nischal KC, Khopkar U. An approach to the diagnosis of neutrophilic dermatoses: a histopathological perspective. Ind J Dermatol Venereol Leprol. 2007; 73: 222-230.

  2. Moschella SL. Neutrophilic dermatosis. In: Bolognia JL. Dermatolgy. España: Elsevier; 2003: pp. 411-424.

  3. Hiari N, Borland C. A 47-year-old man with neuro-Sweet syndrome in association with Crohn’s disease: a case report. J Med Case Reports. 2009; 3: 8997.

  4. Castro-Fernández M, Sánchez-Muñoz D, Ruíz-Granados E, Merchante N, Corzo J. Coexistence of pyoderma gangrenosum and Sweet’s syndrome in a patient with ulcerative colitis. Am J Gastroenterol. 2007; 102: 2865-2866.

  5. Unai G, Eguiluz A, Lobo C, Cosme A, Ojeda E, Lujanda L. Síndrome de Sweet y artritis en una paciente con colitis ulcerosa. Gastroenterol Hepatol. 2007; 30: 506-509.

  6. Malheiros AP, Teixeira MG, Takahashi MD, de Almeida MG, Kiss DR, Cecconello I. Sweet syndrome associated with ulcerative colitis. Inflamm Bowel Dis. 2007; 13: 1583-1584.

  7. Catalán-Serra I, Martín-Moraleda L, Navarro-López L, Gil-Borrás R, Pont-Sanjuán V, Ferrando-Marco J et al. Crohn’s disease and Sweet’s syndrome: an uncommon association. Rev Esp Enferm Dig. 2010; 102: 331-337.

  8. Vij A, Modi GM, Suwattee P, Cockerell CJ, Hsu S. Chronic, recurrent neutrophilic dermatosis: a case report. Dermatol Online J. 2010; 16: 1.

  9. Saeed M, Brown GE, Agarwal A, Pellowski D, Jacks J, Liverett HK et al. Autoimmune clustering: Sweet syndrome, Hashimoto thyroiditis, and psoriasis. J Clin Rheumatol. 2011; 17: 76-78.

  10. Kandula S, Burke WS, Goldfarb JN. Clindamycin-induced Sweet syndrome. J Am Acad Dermatol. 2010; 62: 898-900.

  11. Lund JJ, Stratman EJ, Jose D, Xia L, Wilson D, Moizuddin M. Drug-induced bullous sweet syndrome with multiple autoimmune features. Autoimmune Dis. 2010; 24: 1-4.

  12. Díaz-Peromingo JA, García-Suárez F, Sánchez-Leira J, Saborido-Froján J. Sweet’s syndrome in a patient with acute ulcerative colitis: presentation of a case and review of the literature. Yale J Biol Med. 2001; 74: 165-168.

  13. Duerksen A. Ulcerative colitis and Sweet’s syndrome: a case report and review of the literature. Can J Gastroenterol. 2008; 22 (3): 296-298.

  14. Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol. 2009; 10: 301-312.

  15. Makis A, Stavrou S, Chaliasos N, Zioga A, Vlahos AP, Gaitanis G et al. Acute febrile neutrophilic dermatosis (Sweet’s syndrome) in a child, associated with a rotavirus infection: a case report. J Med Case Reports. 2010; 4: 281.

  16. Mohr MR, Torosky CM, Hood AF, Cunnion KM, Fisher RG, Williams JV. Sweet syndrome in infancy. Pediatr Dermatol. 2010; 27: 208-209.

  17. Foster EN, Nguyen KK, Sheikh RA, Prindiville TP. Crohn’s disease associated with Sweet’s syndrome and Sjögren’s syndrome treated with infliximab. Clin Dev Immunol. 2005; 12 (2): 145-149.

  18. El-Azhary RA, Brunner KL, Gibson LE. Sweet syndrome as a manifestation of azathioprine hypersensitivity. Mayo Clin Proc. 2008; 83: 1026-1030.

  19. Treton X, Joly F, Alves A, Panis Y, Bouhnik Y. Azathioprine-induced Sweet’s syndrome in Crohn’s disease. Inflamm Bowel Dis. 2008; 14: 1757-1758.

  20. Mazokopakis EE, Kofteridis DP, Pateromihelaki AT, Vytiniotis SD, Karastergiou PG. Improvement of ulcerative pyoderma gangrenosum with hyperbaric oxygen therapy. Dermatol Ther. 2011; 24: 134-136.

  21. Chriba M, Skellett AM, Levell NJ. Beclometasone inhaler used to treat pyoderma gangrenosum. Clin Exp Dermatol. 2010; 35: 337-338.

  22. Baglieri F, Scuderi G. Therapeutic hotline. infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report. Dermatol Ther. 2010; 23: 541-543.

  23. Steenbrugge F, Raaijmaakers M, Caekebeke P, Van Landuyt K. Pyoderma gangrenosum following trauma of the knee: a case of pathergy and review of orthopaedic cases. Injury. 2011; 42: 421-423.

  24. Paramkusam G, Meduri V, Gangeshetty N. Pyoderma gangrenosum with oral involvement-case report and review of the literature. Int J Oral Sci. 2010; 2: 111-116.

  25. Fantóbal A, Amaro P. Manifestaciones cutáneas de las enfermedades gastrointestinales. Gastr Latinoam. 2005; 16: 39-57.

  26. Le Cleach L, Moguelet P, Perrin P, Chosidow O. Is topical monotherapy effective for localized pyoderma gangrenosum? Arch Dermatol. 2011; 147: 101-103.

  27. Coelho JF, Lourenço S, Marques J, Mendonça P, Malhado JA. Neutrophilic dermatosis of the dorsal hands associated with chronic hepatitis C virus infection. Indian J Dermatol Venereol Leprol. 2008; 74: 478-480.

  28. Cravo M, Cardoso JC, Tellechea O, Cordeiro MR, Reis JP, Figueiredo A. Neutrophilic dermatosis of the dorsal hands associated with hypopharyngeal carcinoma. Dermatol Online J. 2008; 14: 5.

  29. Byun JW, Hong WK, Song HJ, Han SH, Lee HS, Choi GS et al. A case of neutrophilic dermatosis of the dorsal hands with concomitant involvement of the lips. Ann Dermatol. 2010; 22: 106-109.

  30. Fernández-Fernández FJ, Alvarez-Fernández JC, Romero-Picos E, Garrido JA, Sesma P. Neutrophilic dermatosis of the dorsal hands associated with a «myeloproliferative neoplasm, unclassifiable» and a simultaneous cancer of colon. Acta Medica (Hradec Kralove). 2010; 53: 153-156.

  31. Lee WJ, Kim CH, Chang SE, Lee MW, Choi JH, Moon KC et al. Generalized idiopathic neutrophilic eccrine hidradenitis in childhood. Int J Dermatol. 2010; 49: 75-78.

  32. Bachmeyer C, Aractingi S. Neutrophilic eccrine hidradenitis. Clin Dermatol. 2000; 18: 319-330.

  33. Ng ES, Aw DC, Tan KB, Poon ML, Yap ES, Liu TC et al. Neutrophilic eccrine hidradenitis associated with decitabine. Leuk Res. 2010; 34: e130-e132.

  34. Shear NH, Knowles SR, Shapiro L, Poldre P. Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. J Am Acad Dermatol. 1996; 35 (5 Pt 2): 819-822.

  35. Nijsten TE, Meuleman L, Lambert J. Chronic pruritic neutrophilic eccrine hidradenitis in a patient with Behçet’s disease. Br J Dermatol. 2002; 147: 797-800.

  36. Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol. 2009; 10: 301-312.

  37. Velez AM, Smith JG Jr, Howard MS. Subcorneal pustular dermatosis an immnohisto-pathological perspective. Int J Clin Exp Pathol. 2011; 4: 526-529.

  38. Canpolat F, Akpinar H, Cemil BC, Eskioğlu F, Oztürk E. A case of subcorneal pustular dermatosis in association with monoclonal IgA gammopathy successfully treated with acitretin. J Dermatol Treat. 2010; 21: 114-116.

  39. Berk DR, Hurt MA, Mann C, Sheinbein D. Sneddon-Wilkinson disease treated with etanercept: report of two cases. Clin Exp Dermatol. 2009; 34: 347-351.

  40. Ranieri P, Bianchetti A, Trabucchi M. Sneddon-Wilkinson disease: a case report of a rare disease in a nonagenarian. J Am Geriatr Soc. 2009; 57: 1322-1323.

  41. Sayah A, English JC 3rd. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol. 2005; 53: 191-209.

  42. Kreuter A, Rose C, Zillikens D, Altmeyer P. Bullous rheumatoid neutrophilic dermatosis. J Am Acad Dermatol. 2005; 52: 916-918.

  43. Yamamoto T. Cutaneous manifestations associated with rheumatoid arthritis. Rheumatol Int. 2009; 29 (9): 979-988.

  44. Ergun T, Inanc N, Tuney D, Kotiloglu EK, Seckin D, Tetik C et al. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients. Int J Dermatol. 2008; 47: 894-902.

  45. Defaria D, Kroumpouzos G. Rheumatoid neutrophilic dermatitis as presenting sign of seronegative arthritis. Acta Derm Venereol. 2004; 84: 236-237.

  46. Lazarov A, Mor A, Cordoba M, Mekori YA. Rheumatoid neutrophilic dermatitis: an initial dermatological manifestation of seronegative rheumatoid arthritis. J Eur Acad Dermatol Venereol. 2002; 16: 74-76.

  47. Yamamoto T. Coexistence of bullous rheumatoid neutrophilic dermatosis and palmo plantar pustulosis in a patient with rheumatoid arthritis. Int J Dermatol. 2010; 49: 345-346.

  48. Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Australas J Dermatol. 2011; 52: e5-e7.

  49. Slater GH, Kerlin P, Georghiou PR, Fielding GA. Bowel-associated dermatosis-arthritis syndrome after biliopancreatic diversion. Obes Surg. 2004; 14: 133-135.

  50. Gómez-Diez S, Mas-Vidal A, Soler T, Vázquez-López F, Pérez-Oliva N. Vitamin A deficiency and bowel-associated dermatosis-arthritis syndrome secondary to biliopancreatic diversion for obesity. Actas Dermosifiliogr. 2010; 101: 900-902.

  51. Torrelo A, Patel S, Colmenero I, Gurbindo D, Lendínez F, Hernández A et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol. 2010; 62: 489-495.

  52. Ramot Y, Czarnowicki T, Maly A, Navon-Elkan P, Zlotogorski A. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a case report. Pediatr Dermatol. 2011; 28: 538-541.




2020     |     www.medigraphic.com